Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis
Not yet recruitingOBSERVATIONAL
Enrollment
150
Participants
Timeline
Start Date
April 30, 2025
Primary Completion Date
August 30, 2028
Study Completion Date
August 30, 2028
Conditions
Juvenile Idiopathic Arthritis
Interventions
OTHER
Secukinumab
This is an observational study, there is no treatment allocation.